AliveCor, the global leader in AI-powered cardiology, today announced it has received U.S. Food and Drug Administration (FDA) ...

AliveCor announced today that it received FDA clearance for the next generation of its AI technology for the Kardia 12L ECG ...

Agreement positions NeuralCloud's AI-driven cardiac platform for Holter monitoring and ambulatory patient workflow. Partnership introduces CardioYield™ powered by MaxYield™ for automated, reliable ...

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality globally. Effective management ...

Background: Regular monitoring of performance in ECG stress tests can enable early detection of subtle conduction/morphological changes and enable more accurate risk stratification. However, repeated ...

Outflow tract ventricular arrhythmias (OT-VAs) are the most common type of idiopathic VAs.1 Despite their often benign clinical presentation, patients may experience symptoms that may severely impact ...

Powered by AliveCor's proprietary KAI 12L AI technology, the pocket-sized Kardia 12L ECG System was designed exclusively for healthcare settings to detect 35 cardiac determinations, including heart ...

Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...

GEMS(TM) Rhythm AI Clearance will Address Event, Holter and Long-Term Continuous ECG Monitoring Needs for Remote Patient Monitoring in Canada The GEMS Rhythm arrhythmia and morphology abnormality AI ...

Toronto, Ontario–(Newsfile Corp. – September 30, 2024) – CardioComm Solutions, Inc. (TSXV: EKG) (“CardioComm” or the “Company“), a global medical provider of consumer heart monitoring and medical ...